Disposable Gloves Market In-Depth Research on Market Dynamics, rising CAGR

The global Disposable Gloves Market is expected to reach $ 10,061.0 million by 2023 from $ 6,146.2 million in 2016, recording a CAGR of 7.5% during the forecast period.

The adoption of disposable gloves has increased over the years due to safety concerns and increased hygiene. In addition, coupled with technological advances, the increase in the number of end-users can also help supplement market growth.

However, toxic reactions caused by high price competition between gloves and local manufacturers hinder the growth of the disposable gloves market. For example, accelerators and other chemicals used in the manufacture of latex and non-latex gloves cause allergic reactions such as irritant contact dermatitis. In addition, the introduction of disposable gloves in an undeveloped economy will create a favorable market opportunity.

Download PDF Report Sample with Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/274

Disposable gloves are used at the time of medical examinations and procedures to ensure that there is no cross-contamination between a patient and a caregiver. The use of gloves prevents spreading of infection due to blood flow, pathogens, and other external factors.

The growth of the disposable gloves market is backed by factors such as the need for maintaining safety and hygiene in medical applications, improved healthcare practices, and the growing number of end-users such as healthcare, food industries, etc. However, the toxic reaction from certain gloves and competitive pricing offered by local manufacturers are likely to impede market growth. On the other hand, advancements in technology related to the development of novel disposable gloves are anticipated to provide great opportunities for the market players in the future.

Among the forms discussed, the powdered disposable gloves captured the largest market share in 2016 and are anticipated to maintain its lead throughout the forecast period. The segment is also likely to grow at the fastest CAGR of 4.9%.

Among the types, the non-powdered disposable gloves segment is likely to maintain its lead in terms of revenue, due to its benefits such as the lower risk of side effects. The segment is likely to grow at a CAGR of 11.7% during the forecast period, due to its higher adoption rate. Natural rubber gloves are the most popular gloves used and it is likely to experience a CAGR of 7.2% during the study period.

Medical gloves captured the highest market share in 2016, and it is expected to grow at a CAGR of 6.9% during the forecast period. This is due to the increased use of such gloves for medical examination activities. On the other hand, the high adoption of non-medical gloves in the foodservice industry and cleanroom activities is likely to propel the market for non-medical applications.

The prime companies providing solutions in the global disposable gloves market are

·         Top Glove Corporation Berhad,

·         Supermax Corporation Berhad,

·         Semperit AG Holding,

·         Rubberex Corp. M Bhd,

·         Kossan Rubber Industries Bhd.,

·         Hartalega Holdings Berhad,

·         Dynarex Corporation,

·         Cardinal Health, Inc.,

·         B. Braun Melsungen AG,

·         Ansell Limited

The market in North America is dominant, owing to new product innovations resulting from technological advancements in the region. The launch of advanced products such as puncture-resistant gloves, temperature-resistant gloves, and others has propelled the industry growth. Europe and Asia-Pacific together occupied for nearly half of the market share in 2015.

 Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/274 

Gene Therapy Market Poised to Achieve Significant Growth in the coming Years

Gene Therapy Market accounted for $584 million in 2016, and is estimated to reach $4,402 million by 2023, registering a CAGR of 33.3% from 2017 to 2023. North America is the highest contributor in the gene therapy market in 2016; however, Asia-Pacific is expected to witness the highest growth rate during the forecast period.

Gene therapies are promising therapies applicable to a broad range of diseases; their aim is to radically treat the causes of the diseases instead of only relieving the symptoms. They may be effective on a wide range of previously untreated diseases, such as hematological, ocular, neurodegenerative diseases, and several cancers. For example, adeno-associated AAV2 vectors carrying the therapeutic gene (RPE65) intra-retinal injection resulted in improved vision for people with Lebers Congenital Amaurosis. Gene therapies can be applied either in combination with cell products and through an ex vivo treatment mode (e.g. Strimvelis), or directly administered in vitro (e.g. Glybera). Several vectors present clinically relevant options, including adenovirus (AV), adeno-associated virus (AAV), and lentivirus.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/2841

The key companies profiled in the report include Novartis, Kite Pharma, Inc., GlaxoSmithKline PLC, Spark Therapeutics Inc., Bluebird bio Inc., Genethon, Transgene SA, Applied Genetic Technologies Corporation, Oxford BioMedica, and NewLink Genetics Corp.

Other prominent players in the value chain include Amgen, Epeius Biotechnologies, Abeona Therapeutics, Sanofi, UniQure, Juno Therapeutics, Adaptimmune, Celgene, and Advantagene.

The increase in funding for R&D activities pertaining to gene therapy and increase in awareness regarding gene therapy are the major factors that drive the market growth. In addition, increase in government support, ethical acceptance of gene therapy for cancer treatment, and rise in prevalence of cancer can fuel the growth of the gene therapy market. However, high cost associated with the treatment and unwanted immune responses are expected to hamper the market growth.

Among the vector type, viral vectors contribute to the largest share in 2016, and estimated to retain the same trend during the forecast period. Non-viral vector is anticipated to be a lucrative market due to the technological advancement of these vectors with positive results for these therapies during the preclinical and clinical trials for the treatment of various diseases.

Among the gene type, antigen dominates the overall market accounting for two-ninths of the total share in 2016. Among the applications, oncological disorders is the largest contributor towards the market growth.

In 2016, North America accounted for maximum contribution to the total revenue generated, owing to the high prevalence rate of cancer, presence of high disposable income, and high funding for R&D activities associated with gene therapy. However, Asia-Pacific is expected to witness the highest CAGR during the analysis period, attributable to rise in incidence rate of cancer, increase in government initiative to improve healthcare infrastructure, and rise in healthcare expenditure.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2841

Key Findings of the Gene Therapy Market:

• Non-viral vectors is projected to grow at the highest rate during the analysis period.
• Oncological disorders segment generated the highest revenue, and is expected to continue its dominance in future.
• North America dominated global gene therapy market in 2016, and is projected to continue its dominance in future.
• China is expected to grow highest in the Asia-Pacific region during the forecast period.
• Antigen was the largest contributor among the gene type segments.

Pest Control Market Projected to Grow Faster According to New Research Report

Global pest control market generated $18.21 billion in 2017, and is estimated to garner $27.60 billion by 2025, growing at a CAGR of 5.2% from 2018 to 2025.

The report provides a detailed analysis of top investment pockets, market size and forecasts, value chains, key segments, and competitive scenarios.

Report sample request at https://www.alliedmarketresearch.com/request-sample/2328

Changes in climatic conditions, availability of pest control products, and increased urbanization will drive market growth. However, the health hazards associated with chemicals used to control pests hinder market growth. Meanwhile, new product development and product launches create a new path in the industry.

Industry Key Players

Leading market players analyzed in the research include

·         BASF SE

·         Rentokil Initial Plc.

·         Bayer AG

·         Rollins Inc.

·         Ecolab

·         Anticimex

·         FMC Corporation

·         The ServiceMaster Company LLC

·         Dodson Pest Control Inc.

·         Syngenta

·         Lindsey Pest Services.

Based on type, the chemical segment accounted for nearly one-third of the total market share in 2017 and will maintain its dominance throughout the forecast period. This is due to rise in implementation of chemical pest controlling for its cost-effective nature and rapid application. However, the mechanical segment would register the highest growth rate during the forecast period, with a CAGR of 5.9%, owing to cost-effectiveness, rapid results, and ease in application.

Based on pest type, the insects segment held the major share in 2017, accounting for nearly two-fifths of the total share, and is expected to dominate in terms of revenue throughout the forecast period. This is due to surge in usage of insecticides in households, hospitals, restaurants, farms, and forest plantations. However, the rodents segment would register the largest CAGR of 6.6% from 2018 to 2025, owing to surge in demand for rodents control with increase in food storage capacity. 

North America accounted for the largest share based on revenue in 2017, contributing nearly half of the total market share, and will maintain its leadership status throughout the forecast period. This is due to rise in construction activities, which in turn, increases the demand for pest control in household activities. However, Asia-Pacific is expected to register the highest CAGR of 6.8% from 2018 to 2025, owing to less manufacturing costs and increase in adoption of pest control methods in residential, agricultural, and industrial applications.   

Medical Tourism Market Is Expected to See Extensive Worldwide Growth

Availability and affordability of quality care, accessibility to information, and assistance & support from government agencies and organizations drive the growth in the global medical tourism market

Medical Tourism Market garnered $53.76 billion in 2017, and is expected to reach $143.46 billion by 2025, growing at a CAGR of 12.9% from 2018 to 2025.

Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/454

Key Market Players

Leading market players discussed in the research include Apollo Hospitals Enterprise Limited, Asian Heart Institute, Fortis Healthcare Limited, NTT Medical Center Tokyo, KPJ Healthcare Berhad, UZ Leuven, Seoul National University Hospital, Aditya Birla Memorial Hospital, Wooridul Spine Hospital, Prince Court Medical Centre, Barbados Fertility Center, and Samitivej PCL.

Availability and affordability of quality care, accessibility to information, and assistance & support from government agencies and organizations drive the growth in the market. However, limited coverage and lengthy reimbursements procedures of insurance players and difficulties related to travel, language barriers, documentation, and VISA approval restrain the market growth. Contrarily, overseas promotional offices and wide insurance network under insurance coverage open up new pathways in the industry.

Cosmetic treatment to continue its dominance throughout the forecast period

Cosmetic treatment contributed to more than two-fifths of the total market share in 2017 and is expected to continue its dominance throughout the forecast period. This is due to inclination toward cost-effective procedures that enforces people to travel to the places with inexpensive procedures. However, cancer treatment is expected to grow at the highest CAGR of 15.7% from 2018 to 2025, owing to increase in incidence of cancer across the world and less cost of advanced treatment options in various countries. The research also analyzes dental treatment, cardiovascular treatment, orthopedic treatment, neurological treatment, fertility treatment, and others.

For Purchase Enquiry: https://www.alliedmarketresearch.com/purchase-enquiry/454

North America to maintain its leadership status throughout the forecast period

North America accounted for nearly one-third of the total market share in 2017 and will maintain its leadership status throughout the forecast period. This is due to availability of advanced specialized treatments for neurological, cancer, and cardiovascular ailments along with recent joint commission international (JCI) accreditations, which is considered as the gold standard in the global health care, given to hospitals. Asia-Pacific would witness the highest growth with a CAGR of 8.1% from 2017 to 2023, owing to significant low cost of treatment, tourism friendly nature of the countries, and less stringent regulations associated with cosmetic procedures. The report also discusses Europe and Latin America, Middle East, and Africa (LAMEA).

Germany In Vitro Fertilization (IVF) Market Insights on Market Challenges and New Trends

Germany In Vitro Fertilization (IVF) Market was valued at $398 million in 2018 and is estimated to reach $541 million by 2026, registering a CAGR of 3.9% during the analysis period.

Absence of ability or diminished ability to conceive and bear an offspring is termed as infertility. In vitro fertilization (IVF) is a process that is employed to conceive artificially. The process includes five basic steps such as stimulation, egg retrieval, insemination and fertilization, embryo culture, and embryo transfer. The entire process is performed outside the body and once the embryo is ready, it is implanted in the uterus. In the process fertilization occurs outside the body in a laboratory medium. In vitro fertilization is most often tried when other, less expensive, or invasive fertility techniques have failed. 

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/5483

The major factors that boost the growth of the Germany in vitro fertilization market are subsidizing IVF treatments, delayed marriages & parenting decisions, and rise in number of infertility cases. Furthermore, as per National Health Plan (NHP), about 50% of the treatment cost by IVF paid for three cycles is anticipated to drive the growth of the IVF market in Germany. However, stringent government regulations and lack of availability in treatment cycles for IVF are the major restraints that hinder the growth of the market in Germany. Moreover, surge in adoption of IVF technique in the country is expected to provide remunerative opportunities during the forecast period.

According to cycle type, the fresh IVF cycles acquired the largest Germany in vitro fertilization market share in 2018 owing to increased stability offered by the technique. Moreover, the technique has better outcomes when compared to other techniques which boots the growth of this market. Furthermore, thawed IVF cycles is expected to grow with fastest rate during the forecast period owing to the surge in infertility in the region coupled with the increase in number of IVF clinics.

Based on end user, the fertility clinics in the end user segment generated the highest revenue in 2018. The fertility clinics segment is the largest and the fastest growing segment during the forecast period owing to the presence of large number of fertility clinics.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/5483

Key Findings of the Germany In Vitro Fertilization (IVF) Market:

• By cycle type, fresh IVF cycles in Germany IVF market accounted for largest share in 2018.
• By end user, the fertility clinics segment accounted for three-fourths of the market share in 2018.
• By end user, the clinical research institutes segment is anticipated to account for one-sixth share of the market in 2018.

UK In Vitro Fertilization (IVF) Market Expected to Reach $928 Million, by 2026

UK In Vitro Fertilization (IVF) Market was valued at $514 million in 2018 and is estimated to reach $928 million by 2026, registering a CAGR of 7.6% during the analysis period.

In Vitro Fertilization (IVF) involves using a set of complex procedures to help with conception . The process involves extraction of eggs, retrieving of a sperm sample, and then manually fertilizing them in a fluid medium. In vitro fertilization is most often tried when other, less expensive or invasive fertility techniques have failed. It is also used in the treatment for genetic problems and infertility. It involves five basic steps such as stimulation, egg retrieval, insemination and fertilization, embryo culture, and embryo transfer. IVF is also primarily done for women with infertility owing to damaged or blocked fallopian tubes.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-sample/5484

Commercialization of three-parent IVF procedures, supportive regulations for IVF, rise in incidence of infertility due to changes in lifestyle are the major driving factors for the IVF market in the UK. In addition, surge in awareness about assisted reproductive technology is projected to boost the UK IVF market. However, involvement of social and religious organizations for revaluation of the IVF legislation in the UK hinders the growth of the market. Furthermore, surge in technical advancements related IVF technique boost the growth of the market.  

Fertility clinics and hospitals play an important role in providing IVF treatments to couples seeking assistance for infertility treatments. Fertility clinics provide technologically advanced IVF treatments for patients with fertility problems. The fertility clinics in the end user segment generated the highest revenue in 2018. The fertility clinics segment is the largest and the fastest segment during the forecast period owing to presence of large number of fertility clinics, which are projected to increase during the forecast period. 

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/5484

Key Findings of the UK In Vitro Fertilization (IVF) Market:

• By end user, the fertility clinics segment in the UK IVF market is anticipated to grow at a CAGR of 8.0% from 2019 to 2026.
• By cycle type, the fresh IVF cycles segment in the UK IVF market accounted for two-thirds share of the market share in 2018.

Inhaled Nitric Oxide Market expected to Grow faster with key winning strategies

Increase in demand from healthcare sector drives the demand for inhaled nitric oxide. However, strict application norms across various geographical regions may restraint the growth in the future. Ongoing R&D activities leading to new application areas in healthcare industry present a major opportunity for Inhaled Nitric Oxide Market expansion.

Download PDF Report Sample with statistical info @ https://www.alliedmarketresearch.com/request-toc-and-sample/3020

Nitric oxide or NO is a colorless and odorless gas partially soluble in water. Inhaled nitric oxide is used for the treatment of several respiratory associated diseases.

The report segments the global inhaled nitric oxide market on the basis of application and geography. On the basis of application, it is classified into neonatal respiratory treatment, chronic obstructive pulmonary disease (COPD), malaria treatment, tuberculosis treatment, acute respiratory distress syndrome (ARDS), chronic wound healing, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players, such as Nu-Med Plus, Inc., GENOSYS Inc., Praxair, Inc., Air Liquide S.A., Mallinckrodt Pharmaceuticals, Sigma-Aldrich Co. LLC., Novoteris, LLC, Ikaria Canada Inc., GeNO, LLC., and Perma Pure LLC, are also provided in the report.

Make an Enquiry for Purchase Report @ https://www.alliedmarketresearch.com/purchase-enquiry/3020  

Key Benefits

• This report provides a quantitative analysis of the current trends and estimations from 2017 to 2023 of the global inhaled nitric oxide market to identify the prevailing market opportunities.
• Major countries in each region are mapped according to individual market revenue.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• The report includes an in-depth analysis of current research & clinical developments within the market with key dynamic factors.
• Key players and their key developments in the recent years are listed.